Share Structure - Updated July 29, 2024 Transfer Agent

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
199
Share Structure - Updated July 29, 2024

Transfer Agent Verified Profile - updated at least monthly - often weekly

No change - no dilution for 82 days


Authorized Shares: 5,000,000,000 [same as in January 2020]

Outstanding Shares: 3,100,909,801

Restricted: 237,001,359

Unrestricted: 2,863,908,442

Note1: It is only the Unrestricted Outstanding Shares count that is relevant to immediate trading. This is relatively low at 2.8B for a stock in the .0003 > .25 price range. Some other OTC tickers are adding 10 Billion to 50 Billion on each update.

Note 2: There was no change to the Unrestricted Outstanding Shares November 2, 2022 > December 14, 2023 - total 408 days.

Note 3: An insignificant 112M was added to the Unrestricted Outstanding Shares November 27 > December 14. For context, 216M shares were traded during this period - 193% of the increase.

Note 4: An insignificant 183M was added to the Unrestricted Outstanding Shares December 15 > January 2. For context, 310M shares were traded during this period - 169% of the increase. Also, 145M were traded on December 22 alone - 79% of the increase.

Note 5: An insignificant 127M was added to the Unrestricted Outstanding Shares January 3 > January 16. For context, 186M shares were traded during this period - 146% of the increase. Also, 138M were traded on just January 5 + January 16 - 108% of the increase.

Note 6: An insignificant 133M was added to the Unrestricted Outstanding Shares January 17 > January 28. For context, 331M shares were traded during the period - 249% of the increase. Also, 175M shares were traded on January 19 alone - 131.5% of the increase.

Note 7: An insignificant 140M was added to the Unrestricted Outstanding Shares January 29 > February 10. For context, 377M shares were traded during the period - 269% of the increase. Also, 179M shares were traded on February 6 alone - 128% of the increase.

Note 8: There was no change to the Share Structure February 11 > April 29 - total 79 days.

Note 9: An insignificant 147M was added to the Unrestricted Outstanding Shares April 30 > May 6. For context,129M shares were traded on May 2 alone - 87.75% of the increase. In addition, a further 12M were traded on May 1 and May 6 - 96% of the increase traded.

Note 10: There has been no reverse split during the life of the current company $SFLM or the previous company $SFLM. Self-evidently, with the O/S representing only 62% of the A/S - and only 842M shares added to the Unrestricted O/S during the 20.5-month life of the current company - there is no need or intention to do one.

SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the $2.7 Billion Bid for Papa John’s: An Investment Insight

Updated Category News Views 229

Papa John’s $2.7 Billion Takeover Bid: Insights into Potential Value Recently, shares of Papa John’s International Inc (NASDAQ:PZZA) experienced a notable surge, leading to a halt in trading due to high volatility. This surprising movement came in light of credible reports suggesting a take-private cash offer of $65 per share from TriArtisan Capital Advisors, totaling...

Continue Reading
Key Highlights from Octopus Apollo VCT plc AGM Results

Updated Category News Views 105

Octopus Apollo VCT plc AGM Results Overview Octopus Apollo VCT plc recently conducted its Annual General Meeting (AGM), showcasing significant engagement from shareholders. The meeting aimed to discuss key resolutions impacting the future direction of the company. Voting Outcomes of the AGM The company disclosed that all resolutions were successfully passed during the...

Continue Reading
Carisma Therapeutics Showcases Strong Financial Performance

Updated Category News Views 104

Carisma Therapeutics Showcases Strong Financial Performance Carisma Therapeutics Inc. (NASDAQ: CARM), a clinical-stage biopharmaceutical company, recently released its financial performance for the third quarter of 2024. With a focus on developing innovative immunotherapies, Carisma provided insight into its ongoing projects. Key Developments and Milestones Carisma's...

Continue Reading
Epinephrine Market Growth Insights and Future Potential

Updated Category News Views 112

Overview of the Epinephrine Market The global epinephrine market is on a significant upswing, with recent evaluations estimating its value at USD 3.11 billion and a projected growth to approximately USD 6.39 billion within the next decade. As a critical hormone and neurotransmitter produced by the adrenal glands, epinephrine is essential in treating severe allergic...

Continue Reading
Canadian North Resources Achieves Major Milestones in Q2 2025

Updated Category News Views 183

Canadian North Resources Makes Significant Progress in Operational Strategy Highlights: Canadian North has expanded its bio-metallurgical programs significantly, achieving impressive nickel and cobalt extraction rates through innovative bio-leaching tests. The focus remains on extracting copper and other precious group elements (PGE) metals from the Ferguson Lake Project....

Continue Reading